Global Elotuzumab Market Growth 2025-2031

December 2025 | 76 pages | ID: G5C0326D38BEN
LP Information

Abstracts

The global Elotuzumab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Elotuzumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Elotuzumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Elotuzumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Elotuzumab players cover Bristol Myers Squibb, Abbvie, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Elotuzumab Industry Forecast” looks at past sales and reviews total world Elotuzumab sales in 2024, providing a comprehensive analysis by region and market sector of projected Elotuzumab sales for 2025 through 2031. With Elotuzumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Elotuzumab industry.

This Insight Report provides a comprehensive analysis of the global Elotuzumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Elotuzumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Elotuzumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Elotuzumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Elotuzumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Elotuzumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 300mg Injection
• 400mg Injection

Segmentation by Application:

• Hospital
• Clinic
• Drug Center
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bristol Myers Squibb
• Abbvie

Key Questions Addressed in this Report

What is the 10-year outlook for the global Elotuzumab market?

What factors are driving Elotuzumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Elotuzumab market opportunities vary by end market size?

How does Elotuzumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Elotuzumab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Elotuzumab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Elotuzumab by Country/Region, 2020, 2024 & 2031
2.2 Elotuzumab Segment by Type
  2.2.1 300mg Injection
  2.2.2 400mg Injection
2.3 Elotuzumab Sales by Type
  2.3.1 Global Elotuzumab Sales Market Share by Type (2020-2025)
  2.3.2 Global Elotuzumab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Elotuzumab Sale Price by Type (2020-2025)
2.4 Elotuzumab Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Drug Center
  2.4.4 Others
2.5 Elotuzumab Sales by Application
  2.5.1 Global Elotuzumab Sale Market Share by Application (2020-2025)
  2.5.2 Global Elotuzumab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Elotuzumab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Elotuzumab Breakdown Data by Company
  3.1.1 Global Elotuzumab Annual Sales by Company (2020-2025)
  3.1.2 Global Elotuzumab Sales Market Share by Company (2020-2025)
3.2 Global Elotuzumab Annual Revenue by Company (2020-2025)
  3.2.1 Global Elotuzumab Revenue by Company (2020-2025)
  3.2.2 Global Elotuzumab Revenue Market Share by Company (2020-2025)
3.3 Global Elotuzumab Sale Price by Company
3.4 Key Manufacturers Elotuzumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Elotuzumab Product Location Distribution
  3.4.2 Players Elotuzumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ELOTUZUMAB BY GEOGRAPHIC REGION

4.1 World Historic Elotuzumab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Elotuzumab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Elotuzumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Elotuzumab Market Size by Country/Region (2020-2025)
  4.2.1 Global Elotuzumab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Elotuzumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Elotuzumab Sales Growth
4.4 APAC Elotuzumab Sales Growth
4.5 Europe Elotuzumab Sales Growth
4.6 Middle East & Africa Elotuzumab Sales Growth

5 AMERICAS

5.1 Americas Elotuzumab Sales by Country
  5.1.1 Americas Elotuzumab Sales by Country (2020-2025)
  5.1.2 Americas Elotuzumab Revenue by Country (2020-2025)
5.2 Americas Elotuzumab Sales by Type (2020-2025)
5.3 Americas Elotuzumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Elotuzumab Sales by Region
  6.1.1 APAC Elotuzumab Sales by Region (2020-2025)
  6.1.2 APAC Elotuzumab Revenue by Region (2020-2025)
6.2 APAC Elotuzumab Sales by Type (2020-2025)
6.3 APAC Elotuzumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Elotuzumab by Country
  7.1.1 Europe Elotuzumab Sales by Country (2020-2025)
  7.1.2 Europe Elotuzumab Revenue by Country (2020-2025)
7.2 Europe Elotuzumab Sales by Type (2020-2025)
7.3 Europe Elotuzumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Elotuzumab by Country
  8.1.1 Middle East & Africa Elotuzumab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Elotuzumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Elotuzumab Sales by Type (2020-2025)
8.3 Middle East & Africa Elotuzumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Elotuzumab
10.3 Manufacturing Process Analysis of Elotuzumab
10.4 Industry Chain Structure of Elotuzumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Elotuzumab Distributors
11.3 Elotuzumab Customer

12 WORLD FORECAST REVIEW FOR ELOTUZUMAB BY GEOGRAPHIC REGION

12.1 Global Elotuzumab Market Size Forecast by Region
  12.1.1 Global Elotuzumab Forecast by Region (2026-2031)
  12.1.2 Global Elotuzumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Elotuzumab Forecast by Type (2026-2031)
12.7 Global Elotuzumab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Bristol Myers Squibb
  13.1.1 Bristol Myers Squibb Company Information
  13.1.2 Bristol Myers Squibb Elotuzumab Product Portfolios and Specifications
  13.1.3 Bristol Myers Squibb Elotuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Bristol Myers Squibb Main Business Overview
  13.1.5 Bristol Myers Squibb Latest Developments
13.2 Abbvie
  13.2.1 Abbvie Company Information
  13.2.2 Abbvie Elotuzumab Product Portfolios and Specifications
  13.2.3 Abbvie Elotuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Abbvie Main Business Overview
  13.2.5 Abbvie Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Elotuzumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Elotuzumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 300mg Injection
Table 4. Major Players of 400mg Injection
Table 5. Global Elotuzumab Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Elotuzumab Sales Market Share by Type (2020-2025)
Table 7. Global Elotuzumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Elotuzumab Revenue Market Share by Type (2020-2025)
Table 9. Global Elotuzumab Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Elotuzumab Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Elotuzumab Sale Market Share by Application (2020-2025)
Table 12. Global Elotuzumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Elotuzumab Revenue Market Share by Application (2020-2025)
Table 14. Global Elotuzumab Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Elotuzumab Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Elotuzumab Sales Market Share by Company (2020-2025)
Table 17. Global Elotuzumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Elotuzumab Revenue Market Share by Company (2020-2025)
Table 19. Global Elotuzumab Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Elotuzumab Producing Area Distribution and Sales Area
Table 21. Players Elotuzumab Products Offered
Table 22. Elotuzumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Elotuzumab Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Elotuzumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Elotuzumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Elotuzumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Elotuzumab Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Elotuzumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Elotuzumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Elotuzumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Elotuzumab Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Elotuzumab Sales Market Share by Country (2020-2025)
Table 35. Americas Elotuzumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Elotuzumab Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Elotuzumab Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Elotuzumab Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Elotuzumab Sales Market Share by Region (2020-2025)
Table 40. APAC Elotuzumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Elotuzumab Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Elotuzumab Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Elotuzumab Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Elotuzumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Elotuzumab Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Elotuzumab Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Elotuzumab Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Elotuzumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Elotuzumab Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Elotuzumab Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Elotuzumab
Table 52. Key Market Challenges & Risks of Elotuzumab
Table 53. Key Industry Trends of Elotuzumab
Table 54. Elotuzumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Elotuzumab Distributors List
Table 57. Elotuzumab Customer List
Table 58. Global Elotuzumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Elotuzumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Elotuzumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Elotuzumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Elotuzumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Elotuzumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Elotuzumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Elotuzumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Elotuzumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Elotuzumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Elotuzumab Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Elotuzumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Elotuzumab Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Elotuzumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Bristol Myers Squibb Basic Information, Elotuzumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Bristol Myers Squibb Elotuzumab Product Portfolios and Specifications
Table 74. Bristol Myers Squibb Elotuzumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Bristol Myers Squibb Main Business
Table 76. Bristol Myers Squibb Latest Developments
Table 77. Abbvie Basic Information, Elotuzumab Manufacturing Base, Sales Area and Its Competitors
Table 78. Abbvie Elotuzumab Product Portfolios and Specifications
Table 79. Abbvie Elotuzumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Abbvie Main Business
Table 81. Abbvie Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Elotuzumab
Figure 2. Elotuzumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Elotuzumab Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Elotuzumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Elotuzumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Elotuzumab Sales Market Share by Country/Region (2024)
Figure 10. Elotuzumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 300mg Injection
Figure 12. Product Picture of 400mg Injection
Figure 13. Global Elotuzumab Sales Market Share by Type in 2025
Figure 14. Global Elotuzumab Revenue Market Share by Type (2020-2025)
Figure 15. Elotuzumab Consumed in Hospital
Figure 16. Global Elotuzumab Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Elotuzumab Consumed in Clinic
Figure 18. Global Elotuzumab Market: Clinic (2020-2025) & (K Pcs)
Figure 19. Elotuzumab Consumed in Drug Center
Figure 20. Global Elotuzumab Market: Drug Center (2020-2025) & (K Pcs)
Figure 21. Elotuzumab Consumed in Others
Figure 22. Global Elotuzumab Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Elotuzumab Sale Market Share by Application (2024)
Figure 24. Global Elotuzumab Revenue Market Share by Application in 2025
Figure 25. Elotuzumab Sales by Company in 2025 (K Pcs)
Figure 26. Global Elotuzumab Sales Market Share by Company in 2025
Figure 27. Elotuzumab Revenue by Company in 2025 ($ millions)
Figure 28. Global Elotuzumab Revenue Market Share by Company in 2025
Figure 29. Global Elotuzumab Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Elotuzumab Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Elotuzumab Sales 2020-2025 (K Pcs)
Figure 32. Americas Elotuzumab Revenue 2020-2025 ($ millions)
Figure 33. APAC Elotuzumab Sales 2020-2025 (K Pcs)
Figure 34. APAC Elotuzumab Revenue 2020-2025 ($ millions)
Figure 35. Europe Elotuzumab Sales 2020-2025 (K Pcs)
Figure 36. Europe Elotuzumab Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Elotuzumab Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Elotuzumab Revenue 2020-2025 ($ millions)
Figure 39. Americas Elotuzumab Sales Market Share by Country in 2025
Figure 40. Americas Elotuzumab Revenue Market Share by Country (2020-2025)
Figure 41. Americas Elotuzumab Sales Market Share by Type (2020-2025)
Figure 42. Americas Elotuzumab Sales Market Share by Application (2020-2025)
Figure 43. United States Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Elotuzumab Sales Market Share by Region in 2025
Figure 48. APAC Elotuzumab Revenue Market Share by Region (2020-2025)
Figure 49. APAC Elotuzumab Sales Market Share by Type (2020-2025)
Figure 50. APAC Elotuzumab Sales Market Share by Application (2020-2025)
Figure 51. China Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 55. India Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Elotuzumab Sales Market Share by Country in 2025
Figure 59. Europe Elotuzumab Revenue Market Share by Country (2020-2025)
Figure 60. Europe Elotuzumab Sales Market Share by Type (2020-2025)
Figure 61. Europe Elotuzumab Sales Market Share by Application (2020-2025)
Figure 62. Germany Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 63. France Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Elotuzumab Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Elotuzumab Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Elotuzumab Sales Market Share by Application (2020-2025)
Figure 70. Egypt Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Elotuzumab Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Elotuzumab in 2025
Figure 76. Manufacturing Process Analysis of Elotuzumab
Figure 77. Industry Chain Structure of Elotuzumab
Figure 78. Channels of Distribution
Figure 79. Global Elotuzumab Sales Market Forecast by Region (2026-2031)
Figure 80. Global Elotuzumab Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Elotuzumab Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Elotuzumab Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Elotuzumab Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Elotuzumab Revenue Market Share Forecast by Application (2026-2031)